Detalhe da pesquisa
1.
Administration of oxathridine, a first-in-class histamine-3 receptor partial agonist in healthy male volunteers: Central nervous system depression and pseudo-hallucinations.
Br J Clin Pharmacol
; 90(1): 321-335, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37724688
2.
Kinetics of myelin breakdown products: A labeling study in patients with progressive multiple sclerosis.
Clin Transl Sci
; 15(3): 638-648, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34799987
3.
Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double-blind, placebo-controlled cross-over trial.
CNS Neurosci Ther
; 25(6): 697-703, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30756475